amantadine has been researched along with Epilepsy, Absence in 5 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Epilepsy, Absence: A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amantadine has demonstrated efficacy in small series for absence and myoclonic type seizures." | 1.38 | Amantadine for the treatment of refractory absence seizures in children. ( Bailey, LJ; Hernandez, AW; Kotecha, AC; Malik, SI; Perry, MS, 2012) |
| "Amantadine hydrochloride was administered as an add-on drug to four children with refractory absence epilepsy, resulting in complete resolution of absence episodes within 1 week." | 1.28 | Effect of add-on amantadine therapy for refractory absence epilepsy. ( Brand, N; Shahar, EM, 1992) |
| "Amantadine was added to the existing regimens in weekly increments to 400 mg/day." | 1.28 | Amantadine hydrochloride for refractory generalized epilepsy in adults. ( Denio, LS; Drake, ME; Pakalnis, A; Phillips, B, 1991) |
| "Amantadine HCl was given to 10 children with medically refractory seizures; other anticonvulsant medications were continued unchanged through the 12- to 16-week trial." | 1.27 | Amantadine in the treatment of refractory epilepsy in childhood: an open trial in 10 patients. ( Chugani, HT; Lake, JL; Shields, WD, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perry, MS | 1 |
| Bailey, LJ | 1 |
| Kotecha, AC | 1 |
| Malik, SI | 1 |
| Hernandez, AW | 1 |
| Matsushige, T | 1 |
| Matsufuji, H | 1 |
| Ichiyama, T | 1 |
| Furukawa, S | 1 |
| Shahar, EM | 1 |
| Brand, N | 1 |
| Drake, ME | 1 |
| Pakalnis, A | 1 |
| Denio, LS | 1 |
| Phillips, B | 1 |
| Shields, WD | 1 |
| Lake, JL | 1 |
| Chugani, HT | 1 |
5 other studies available for amantadine and Epilepsy, Absence
| Article | Year |
|---|---|
Amantadine for the treatment of refractory absence seizures in children.
Topics: Amantadine; Child; Child, Preschool; Dopamine Agents; Epilepsy, Absence; Female; Follow-Up Studies; | 2012 |
[A girl with refractory childhood absence epilepsy improved by add-on amantadine therapy].
Topics: Amantadine; Anticonvulsants; Child; Drug Administration Schedule; Electroencephalography; Epilepsy, | 2007 |
Effect of add-on amantadine therapy for refractory absence epilepsy.
Topics: Amantadine; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Electroencephalogra | 1992 |
Amantadine hydrochloride for refractory generalized epilepsy in adults.
Topics: Adolescent; Adult; Amantadine; Anticonvulsants; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, | 1991 |
Amantadine in the treatment of refractory epilepsy in childhood: an open trial in 10 patients.
Topics: Adolescent; Amantadine; Child; Child, Preschool; Epilepsies, Myoclonic; Epilepsy, Absence; Female; H | 1985 |